UNSPSC 51144200: Stimulant or anorexiant azoles

This classification denotes substances composed of five-membered rings that contain a nitrogen atom, substances called azoles, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term STIMULANT OR ANOREXIANT AZOLES.

UNSPSC 51144200 Stimulant or anorexiant azoles is a Class code that state and local governments use to classify pharmaceutical procurement, though recent activity shows a broader mix of pharmaceutical and health-supply acquisitions beyond the narrow scope of the code's nominal name. State and local issuing bodies soliciting under this code include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances that aggregate demand across multiple jurisdictions and member agencies. The work being solicited spans naloxone and drug deactivation systems for emergency response, direct-to-manufacturer prescription programs managed through state pharmacy benefit initiatives, and generic pharmaceutical and over-the-counter product supply contracts distributed through authorized wholesalers to public facilities.

Recent activity centers on Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, response deadline July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor information on direct-to-manufacturer prescription programs and alternative contracting models outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities including Oregon, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. Vendors participating in MMCAP must maintain relationships with authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, and comply with cGMP and Drug Supply Chain Security Act certification requirements.